Antisense modulation of integrin .alpha.4 expression

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/711 (2006.01) A61P 11/00 (2006.01)

Patent

CA 2584614

A method for the treatment and/or prophylaxis of an animal having a respiratory disease or condition associated with airway hyperresponsiveness, eosinophilia, neutrophilia, leukocytes or overproduction of mucus and/or with the expression of integrin .alpha.4 comprising administering to the animal a composition comprising from. 0.001 to 1000 ~g per kg body weight of the animal of an antisense compound targeted to a nucleic acid molecule encoding integrin .alpha.4.

La présente invention décrit une méthode de traitement prophylactique et/ou thérapeutique d'un animal souffrant d'une maladie respiratoire ou d'un état pathologique associé à une hyperréactivité des voies respiratoires, à l'éosinophilie, à la neutrophilie, aux leucocytes ou à la surproduction de mucus et/ou accompagné de l'expression de l'intégrine .alpha.4, ladite méthode comprenant l'administration à l'animal d'une préparation comprenant entre 0,001 et 1000 µg par kg de masse corporelle de l'animal d'un composé antisens ciblant une molécule d'acide nucléique codant pour l'intégrine .alpha.4.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Antisense modulation of integrin .alpha.4 expression does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antisense modulation of integrin .alpha.4 expression, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antisense modulation of integrin .alpha.4 expression will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1602678

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.